| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Pulse Biosciences, Inc. (PLSE) has 8 insiders with recent SEC Form 4 filings, including 33 buys and 5 sells. PLSE is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 47.55M | $1.14B | - | |
| Other | 100.0K | $2.39M | - | |
| Other | 55.0K | $1.32M | - | |
| Other | 43.3K | $1.04M | - | |
| Dir | 30.0K | $717.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 14, 2017 | Levinson Mitchell E. | Director | Buy | 3,835 | $12.30 | $47,170.07 | New | |
| Aug 3, 2017 | Zanganeh Maky84 | Director | Buy | 28,790 | $23.96 | $689,800.63 | +3.0% | |
| Aug 3, 2017 | Duggan Robert W76 | 10% Owner | Buy | 277,450 | $23.14 | $6,419,318.11 | +1.1% | |
| May 23, 2017 | Duggan Robert W76 | 10% Owner | Buy | 83,928 | $26.86 | $2,254,330.47 | +0.5% | |
| May 12, 2017 | Thaure Thierry B. | Director | Sale+OE | 10,000 | $24.40 | $244,000.00 | -66.7% | |
| May 11, 2017 | Zanganeh Maky84 | Director | Buy | 53,760 | $20.49 | $1,101,585.32 | +13.7% | |
| May 11, 2017 | Duggan Robert W76 | 10% Owner | Buy | 43,389 | $21.04 | $912,889.67 | +0.3% | |
| May 10, 2017 | Greenberg Robert J. | Director | Sale+OE | 25,000 | $21.12 | $528,110.34 | -89.9% | |
| May 8, 2017 | Thaure Thierry B. | Director | Sale+OE | 15,000 | $22.49 | $337,320.00 | -100% | |
| May 2, 2017 | Duggan Robert W76 | 10% Owner | Buy | 84,348 | $23.88 | $2,013,964.58 | +1.0% |